Pharmaceuticals in Japan - Research and Markets

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The Japanese pharmaceuticals market registered revenue of $94.3 billion in 2023, representing a compound annual growth rate (CAGR) of 7.3% between 2018 and 2023.
Japan captured a share of 24.1% in the Asia-Pacific pharmaceuticals market, in 2023.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Japan pharmaceuticals market by value in 2023?
What will be the size of the Japan pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Japan pharmaceuticals market?
How has the market performed over the last five years?
How large is Japan’s pharmaceuticals market in relation to its regional counterparts?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the recent developments in the market?

8 Company Profiles

8.1. Otsuka Holdings Co Ltd
8.2. Astellas Pharma Inc
8.3. Takeda Pharmaceutical Co Ltd
8.4. Daiichi Sankyo Co Ltd

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Japan pharmaceuticals market value: $ billion, 2018-23
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: Otsuka Holdings Co Ltd: Key Facts
Table 5: Otsuka Holdings Co Ltd: Annual Financial Ratios
Table 6: Otsuka Holdings Co Ltd: Key Employees
Table 7: Otsuka Holdings Co Ltd: Key Employees Continued
Table 8: Astellas Pharma Inc: Key Facts
Table 9: Astellas Pharma Inc: Annual Financial Ratios
Table 10: Astellas Pharma Inc: Key Employees
Table 11: Takeda Pharmaceutical Co Ltd: Key Facts
Table 12: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 13: Takeda Pharmaceutical Co Ltd: Key Employees
Table 14: Takeda Pharmaceutical Co Ltd: Key Employees Continued
Table 15: Daiichi Sankyo Co Ltd: Key Facts
Table 16: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 17: Daiichi Sankyo Co Ltd: Key Employees
Table 18: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 20: Japan Size of Population (million), 2019-23
Table 21: Japan Real GDP (constant 2010 prices, $ billion), 2019-23
Table 22: Japan GDP (current prices, $ billion), 2019-23
Table 23: Japan Inflation, 2019-23
Table 24: Japan Consumer Price Index (absolute), 2019-23
Table 25: Japan Exchange Rate, 2018-23

List of Figures

Figure 1: Japan pharmaceuticals market value: $ billion, 2018-23
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2023-28
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2023
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2023
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2023
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2023
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2023
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Otsuka Holdings Co Ltd
Astellas Pharma Inc
Takeda Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€349EUR$350USD£292GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€523EUR$525USD£438GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€698EUR$700USD£583GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceutical Industry Outlook, 2024

Asia-Pacific Pharmaceutical Industry Outlook 2023

Fecal Transplant Therapy Market Report 2024

Pharmaceuticals in Asia-Pacific

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028